Milademetan Tosylate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Milademetan Tosylate, covering 2023-06-15 to 2023-06-15. Get the full timeline:
Most recent: Clinical Trial Update: Milademetan Tosylate and Low-Dose Cytarabine With or Without Venetoclax in Treating Participants With Recurrent or Refractory Acute Myeloid Leukemia [Phase 1, Phase 2]